Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Defends Spray-Sunscreen Monograph Viability

This article was originally published in The Tan Sheet

Executive Summary

Energizer Personal Care, owner of the Banana Boat and Hawaiian Tropic brands, says study data support the inclusion of spray sunscreens in the over-the-counter drug monograph for sunscreen products.

You may also be interested in...



Banana Boat Sunscreen Recall Could Raise Questions On Spray Standards

Energizer Personal Care’s recall of 23 Banana Boat spray sunscreen SKUs came in response to five reports of consumers burned after using the products. A broader problem may be the lack of a formal or recognized industry standard for dispensing volumes of continuous spray sunscreens.

Spray Sunscreen Review Heats Up As FDA Looks Into Burn Report

FDA launched an inquiry following a report that a man suffered second-degree burns after using a Banana Boat spray sunscreen from Energizer Personal Care. The firm has submitted to FDA data showing the safety and efficacy of spray sunscreens, in support of their inclusion in the final monograph.

Spray Sunscreen Review Heats Up As FDA Looks Into Burn Report

FDA launched an inquiry following a report that a man suffered second-degree burns after using a Banana Boat spray sunscreen from Energizer Personal Care. The firm has submitted to FDA data showing the safety and efficacy of spray sunscreens, in support of their inclusion in the final monograph.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105383

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel